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The efficacy of the adaptive humoral immune response likely requires diverse, yet
focused regional B cell antibody production throughout the body. Here we address, in
the first study of its kind, the B cell repertoire in the bronchial mucosa, an important
barrier to antigens inhaled from the atmosphere. To accomplish this, we have applied
high-throughput Adaptive Immune Receptor Repertoire Sequencing (AIRR-Seq) to 10
bronchial biopsies from altogether four different sites in the right lungs from an asthmatic
patient and a healthy subject. While the majority of identified B cell clones were restricted
to a single site, many were disseminated in multiple sites. Members of a clone were
shared more between adjacent biopsies than between distal biopsies, suggesting local
mucosal migration and/or a homing mechanism for B cells through the blood or lymph.
A smaller fraction of clones spanned the bronchial mucosa and peripheral blood,
suggesting ongoing trafficking between these compartments. The bronchial mucosal B
cell repertoire in the asthmatic patient was geographically more variable but less diverse
compared to that of the healthy subject, suggesting an ongoing, antigen-driven humoral
immune response in atopic asthma. Whether this is a feature of atopy or disease status
remains to be clarified in future studies. We observed a subset of highly mutated and
antigen-selected IgD-only cells in the bronchial mucosa. These cells were found in relative
high abundance in the asthmatic individual but also, albeit at lower abundance, in the
healthy subject. This novel finding merits further exploration using a larger cohort of
subjects.
Keywords: asthma, B-cell antibody repertoire, bronchial mucosa, clonal dissemination, cell trafficking, next
generation sequencing, somatic hypermutation
INTRODUCTION
B cells form an essential plank of the adaptive immune response to environmental assaults at
mucosal surfaces. The airways mucosa is a very large surface open to such assault, with B cells
situated in the bronchial mucosa between the pseudostratifed squamous epithelium of the airways
on the outside and themucosal parenchyma containing blood and lymphatic capillaries and flanked
by smooth muscle and cartilage on the inside (1).
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We have previously shown that B cells in the bronchial
mucosa are activated in response to environmental assaults in
an antigen-specific fashion and undergo somatic hypermutation
(SHM) with class switching, affinity maturation and plasma
cell differentiation to produce high-affinity antibodies at the
site of the assault (2, 3). Nevertheless, because of the practical
difficulties associated withmultiple and repetitive sampling of the
mucosa in humans, there currently exists remarkably little direct
evidence as to whether proliferating and maturing B cells remain
confined locally within the mucosa near the site of activation,
or alternatively whether they become widespread geographically
at an early stage, and how this process is influenced by ongoing
mucosal inflammation.
Recent advances in technology, particularly with high-
throughput Adaptive Immune Receptor Repertoire Sequencing
(AIRR-Seq) have provided scientists with a unique new tool
with which to pinpoint sites of B cell maturation and uncover
trafficking pathways within and between organs (4). We have
previously used this technology to show evidence of allergen-
driven SHM in the nasal mucosa of hay fever sufferers during
the pollen season (5). We have also used it to uncover
B cell trafficking between the central nervous system and
lymphoid tissues in patients with multiple sclerosis (6). Others
have observed distinct antibody repertoires in mucosal tissue
compared to blood and lymphoid tissue in healthy individuals
(7), and a large degree of sharing of sequences (“connectivity”)
between different regions of the gastrointestinal tract (8, 9).
Within the gastrointestinal tract the immunoglobulin repertoires
from various sites were found to be highly related to each other
but to be less related to the antibodies from the blood, bone
marrow, spleen and lung (9).
In the present study we have devised a more extensive
strategy to study the maturation of B cells in situ within the
bronchial mucosa in the context of environmentally-induced
inflammation, using asthma as an archetypal example of this
phenomenon. Our strategy was to obtain two or three bronchial
biopsies from each of four specific sites within the bronchial tree
extending from the carina to the third or fourth generation of
the bronchial tree from one asthmatic (AA) and one healthy
subject (NANA) and to use AIRR-Seq to examine in great detail
the diversity of the immunoglobulin receptor repertoire and the
interrelationships between this repertoire in distinct areas of the
bronchial mucosa as well as the peripheral blood.
Our experiments were designed to determine (1) whether or
not the bronchial mucosa is a site of activation of B cells as
evidenced by in situ SHM and immunoglobulin class switching;
(2) whether or not the bronchial mucosal immunoglobulin
repertoire is diverse or restricted in terms of isotypes and
gene usage and shows signs of antigen-driven selection; and
(3) whether or not locally clonally expanded cells are able to
migrate to more remote sites within the bronchial mucosa and
the peripheral blood.
MATERIALS AND METHODS
Participants
Bronchial biopsies and peripheral blood were obtained from
one atopic asthmatic (AA) and one non-atopic non-asthmatic
(NANA). The study was conducted at and in accordance with
the recommendations of King’s College London and Guy’s and St
Thomas’ NHS Foundation Trust and the protocol was approved
by the London Central Research Ethics Committee (REC number
15/LO/1800). Both subjects gave written informed consent in
accordance with the Declaration of Helsinki. The criteria for the
diagnosis of asthma and atopy have been described previously
(10).
Peripheral Blood and Tissue Sample
Collection and Processing
Bronchial biopsies were obtained at fibreoptic bronchoscopy
from four distinct sites within the airways of the right lung,
namely around the origin of the right main bronchus near the
carina and then around the origins of 1st, 2nd, and 3rd or 1st,
3rd, and 4th generation bronchi further down the bronchial tree
as shown later. Samples were obtained in reverse order (from
the base of the lung upwards) to minimize cross-contamination.
A total of 3-5 biopsies was obtained from each site, equating
to a total of 15 from the atopic asthmatic AA and 12 from the
healthy subject NANA, although only 10 biopsies were analyzed
from each individual. Biopsies were immediately immersed
in RNAlater (Life Technologies) and stored at 4◦C overnight
prior to long term storage in liquid nitrogen. Two or three
biopsies from each site were chosen for sequencing based on
the highest yields of RNA. 40ml of venous blood were collected
into 1:10 ACD (anticoagulant-citrate-dextrose) (Sigma-Aldrich)
immediately before the bronchoscopy procedure. PBMCs were
isolated by centrifugation over Ficoll-Paque (GE Health Care)
according to the manufacturer’s instructions and stored in
freezing medium (10% dimethyl sulphoxide in fetal calf serum)
in liquid nitrogen. Aliquots of 107 cells were used in the following
RNA extraction step.
RNA Extraction and Next Generation
Sequencing
Total RNA was extracted from the biopsies by disrupting the
tissue in a TissueLyser (Qiagen) using 5mm stainless steel beads,
followed by centrifugation through a Qiashredder (Qiagen) and
extraction using the RNeasy Plus Micro Kit (Qiagen), according
to manufacturers’ instructions. PBMC RNA was extracted using
the RNeasy Plus Mini Kit (Qiagen). Both kits included a step to
remove genomic DNA. All the RNA extracted from each biopsy
and a minimum of 1mg PBMC RNA was shipped to iRepertoire
(iRepertoire Inc., Huntsville, Alabama, USA) for sequencing of
the immunoglobulin heavy chain repertoire on the Illumina
MiSeq platform with 250 bp paired-end reads. iRepertoire use
their own patent protected primers including VH-gene family
specific forward primers in the heavy chain FWR1 region and
isotype-specific primers in the CH1 constant region. All samples
were sequenced in two sequencing runs.
Sequencing Data Processing
iRepertoire provided filtered and merged reads processed
as previously described (11). Additional data processing is
described in detail in the Supplementary Methods section.
Briefly, the sequences from iRepertoire were analyzed with
ImMunoGeneTics (IMGT)/High V-QUEST to determine V(D)J
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assignments (12). The data were then processed with the Change-
O v0.3.2 (13), Alakazam v0.2.5 (13) SHazaM v0.1.4 (13), and
other custom scripts through the R environment (14). Filtering
steps included discarding sequences with mismatches in the
constant region, sequences with more than six mismatches in
a 10 nucleotide stretch and sequences with a copy number
below five (below one for IgE). Non-functional sequences were
also removed from the data, and clonally related sequences
were identified using a clustering-based approach as detailed in
the Supplementary Methods (13). A detailed description of the
various analyses performed can be found in figure legends and
Supplementary Methods. In accordance with AIRR Community
recommendations (15) the data set can be found at NCBI’s
sequence read archive (SRA), https://www.ncbi.nlm.nih.gov/sra,
under BioProject accession PRJNA422604.
RESULTS
B Cells in the Human Bronchial Mucosa
Have a Highly Diverse Immunoglobulin
Repertoire
Ten bronchial biopsies from four distinct sites in the bronchial
mucosa were collected at fibreoptic bronchoscopy from two
individuals, one atopic asthmatic (AA) and one non-atopic, non-
asthmatic healthy subject (NANA). A peripheral blood sample
was also collected at the same time. Total RNA was extracted
from the tissue and blood samples and the immunoglobulin
heavy chains were amplified from the end of framework region
1, FWR1, and into the 5′ end of the heavy chain CH1
domain and subsequently sequenced using Adaptive Immune
Receptor Repertoire Sequencing (AIRR-Seq) on the Illumina
MiSeq platform. A total of 6,782,411 sequences (AA: 3,129,960
and NANA: 3,652,451) were generated. After quality control
(QC), filtering and trimming, a total of 238,928 unique sequences
(AA: 121,507, and NANA: 117,421) of high quality were retained
and used for the analyses described below (Table S1).
We found that all of the bronchial mucosal biopsies from
AA contained a mixed repertoire of IgD, IgM, IgG and IgA
clones (Table 1 and Figure 1A). No IgE clones were found
(see Discussion). The pattern was distinct from that in the
biopsies from NANA where fewer IgM and practically no IgD
clones were identified (Table 1 and Figure 1B), compatible with
the hypothesis that, in healthy individuals, principally mature,
isotype switched memory B cells reside in the bronchial mucosa.
This is further supported by the finding that the mean mutation
frequency of the clones from NANA was relatively constant
(∼7%) in all 10 biopsies (Figure 1D), whereas themeanmutation
frequency varied from ∼4 to 8% in individual biopsies from AA
(Figure 1C) with biopsies featuring the highest percentages of
IgM clones (AB2, AB9, and AB11, see Figure 1A) showing the
lowest meanmutation frequency. For all isotypes, the clones from
AA contained a wider range in terms of numbers of sequences per
clone than those fromNANA (Table 1). Together with the finding
of high proportions of IgD and IgM clones in some of the biopsies
from AA, these findings are compatible with the hypothesis that
the inflamed bronchial mucosa is a site of local recruitment of
naïve B cells.
Ongoing immune activity is often characterized by clonal
expansion of B cells and an accompanying loss of clonal diversity
(9). To compare this diversity further we used the method
of Hill (16) to measure multiple aspects of diversity in both
subjects. In terms of numbers of distinct clones and size of
the most expanded clone, we found that the repertoire of
the healthy subject was more diverse than that of the atopic
asthmatic. This was true when considering all sequences together
and separately in the bronchial mucosa and peripheral blood
(Figures 2A,B). With the exception of biopsy 9 from AA, the
diversity appeared to be greater in peripheral blood than in
TABLE 1 | Numbers of unique sequences and clones retained after all filtering and quality control steps.
AA
Bronchial mucosaa
AA
Blood
NANA
Bronchial mucosaa
NANA
Blood
No of sequences No of clones No of sequences No of clones No of sequences No of clones No of sequences No of clones
IgD 7,424 449
(1–1,281; 3)*
1,252 1,146
(1–10; 1)*
411 28
(1–304; 3)*
2,670 2,280
(1–25; 1)*
IgM 19,346 748
(1–7,718; 3)*
3,227 2,497
(1–42; 1)*
2,911 350
(1–416; 3)*
10,635 7,988
(1–33; 1)*
IgG 62,867 563
(1–6,808; 11)*
5,585 400
(1–1,388; 5)*
71,728 933
(1–2,178; 20)*
4,061 579
(1–79; 4)*
IgA 20,126 763
(1–5,238; 3)*
1,458 509
(1–74; 2)*
19,616 1,402
(1–1,906; 4)*
2,412 1,049
(1–25; 1)*
IgE 0 0 222 101
(1–83; 1)*
1 1
(1–1; 1)*
2,976 336
(1–1,387; 1)*
Total 109,763 1,719
(1–7,718; 4)*
11,744 4,327
(1–1,388; 1)*
94,667 2,090
(1–2,178; 6)*
22,754 11,458
(1–1,387; 1)*
AA: atopic asthmatic patient, NANA: non-atopic, non-asthmatic individual.
aAll ten biopsies from the individual combined.
*The numbers in the parenthesis give the range (minimum to maximum) and the median of the number of sequences per clone.
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individual biopsies (Figures 2C,D). It is interesting to note that
the Hill plots for individual biopsies from NANA were more
uniform than those from theAA, supporting the conclusion from
the mutation analysis that the between-biopsy variability was
larger in AA compared with NANA. In terms of diversity, the
mucosal antibody repertoire from NANA was significantly more
diverse than that from the asthmatic patient AA as seen from the
Shannon and Simpson indices (P = 0.03 and 0.01, respectively)
(Figures 2E,F). Overall, the bronchial mucosa of the asthmatic
subject contained fewer unique sequences with a greater degree
of clonal expansion, suggesting a narrowing of overall diversity
consistent with an ongoing immune response.
It has previously been found that genes from the VH5 family
are over-expressed in IgE from B cells in the asthmatic bronchial
mucosa (17). Prompted by this, we analyzed the VH gene usage
of individual clones from B cells from the bronchial mucosa
and peripheral blood of our two subjects. The repertoires were
dominated by VH3 and VH4 family genes followed by VH1
(Figures 1E,F), which is expected for peripheral blood from
previously reported findings (18). Very few of the clones used
genes from VH2, VH5, VH6, and VH7 families, with no VH7
genes from any of the samples from NANA. Despite the overall
low usage, we did find that VH5 was significantly over expressed
in the bronchial mucosa compared to the peripheral blood
of both subjects (P < 0.05, Chi-squared). This was true for
all isotypes except for IgD from NANA where the number of
bronchial mucosal clones identified (28 in total) was insufficient
for this type of analysis. There were no striking differences in the
patterns of VH gene usage between AA and NANA. Thus, the
bronchial mucosa immunoglobulin repertoire was highly diverse
in terms of VH gene usage, but exhibited a significant bias toward
VH5 family usage in the bronchial mucosa compared to the
peripheral blood.
Mutation Patterns Are Consistent With
Antigen-Driven Selection
To investigate the levels of SHM in more depth we compared the
mutation frequencies found in mucosa-derived clones to those
from peripheral blood. For all isotypes in both subjects, with the
exception of IgE for which we could detect no bronchial mucosal-
derived sequences, we found that clones from the mucosa were
significantly more mutated than those from the peripheral blood
(Figures 3A,B). Despite these overall differences in the mutation
frequencies, sequences from bronchial mucosa and peripheral
blood derived from the same clone showed similar mutation
frequencies (Figure 2C). The clones with members in both tissue
and peripheral blood spanned the entire range of mutation
frequencies and included clones in germline configuration
(Figure 3C). Overall, the mutation frequencies that we observed
in clones from the peripheral blood were consistent with previous
findings (19) in both individuals, with IgG and IgA showing the
highest mutation frequency (ca. 6%), followed by IgE (ca. 5%),
and IgM and IgD (ca. 1%). The IgM and IgD sequences were
mostly unmutated and thus presumably originated from naïve
B cells, although the analysis did reveal the presence of some
mutated memory sequences. There are no previous, isotype-
specific, large-scale data from the bronchial mucosa, but in nasal
biopsies from patients with rhinitis Wu et al. (5) found an IgM
mutation frequency of ca. 4.5% (comparable to our ca. 4.5%
in AA and ca. 5.5% in NANA), and a combined IgA and IgG
mutation frequency of about 9%, which is somewhat higher than
the 6-7% found in our present data.
The process of SHM is driven by activation-induced cytidine
deaminase (AID) and error-prone repair pathways, both of which
have a well-characterized sequence bias (20, 21). In conventional
germinal center reactions, the mutation process itself is followed
by selection that further shapes the mutation patterns seen
in antigen-driven selection (22). To investigate whether these
same processes were driving the observed diversification in the
bronchial mucosal repertoire, we first analyzed the distribution
of mutations across the sequences. As expected, most mutations
were located in the complementarity determining regions
(CDRs) with spikes in known hotspot areas, including framework
region 3 (FWR3) (Figures S1A,B). We refined the analysis to
look at the mutability of DNA 5-mer motifs containing known
SHM hot-, cold- and neutral spots (Figure S2A). This analysis
showed that, across all isotypes and all sample types in both
individuals, mutations occurred more frequently in the hotspots
than in the cold and neutral spots. These mutation patterns are
consistent with typical SHM targeting (21). To test whether the
mutation patterns showed evidence of antigen-driven selection,
we used the algorithm BASELINe (23) (see Supplementary
Methods) to quantify selection strength. The selection pressure
was slightly positive in the CDRs of the clones of all isotypes from
the peripheral blood from both AA and NANA (Figures 4B,D),
and in the bronchial mucosal clones from AA (Figure 4A). It was
neutral in the bronchial mucosal clones from NANA, suggesting
a lesser degree of antigen-driven selection in this compartment
(Figure 4C). Although these data also suggest slight variation
according to antibody isotype, a more detailed analysis with a
larger cohort of patients will be required in future studies to
clarify whether and how far the degree of selection is isotype-
dependent. The selection pressure was negative in all FWRs
consistent with previous results, and the expectation that many
amino acid changes in this region will be selected against in order
to maintain structural integrity (24). These data are consistent
with a scenario of maturation driven by typical SHM along with
antigen-driven selection of the B cells in the bronchial mucosa.
B Cell Clones Are Widely Dispersed
Throughout the Bronchial Mucosa
To determine whether the clonal expansion observed in
the bronchial mucosa B cells was associated with migration
throughout the tissue, we analyzed the pattern of sharing across
the multiple biopsies within the bronchial mucosa. All possible
pairs of biopsies shared several clones (Figures 5A,B - upper
triangle), with the degree of overlap ranging from 2% (one of
49 AB6 clones related to AB12) to 48% (58 of 120 AB3 clones
related to AB1) of all clones per biopsy pair. In most cases, we
were even able to identify identical sequences from biopsy pairs
(Figures 5A,B - lower triangle) but the percentages were lower
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FIGURE 1 | The human bronchial mucosal repertoire is highly diverse and distinct from the peripheral blood repertoire. For each biopsy and peripheral blood sample
from (A) the asthmatic patient AA and (B) the healthy subject NANA, the percentages of IgD (orange), IgM (purple), IgG (green), IgA (blue), and IgE (red) clones were
(Continued)
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FIGURE 1 | calculated as a fraction of the total numbers of clones [the numbers of clones in each sample are the same as in (C,D)]. The mutation frequencies for
each clone were calculated as described in the Supplementary Methods, and the distribution of the frequencies in each sample (10 individual biopsies and one
peripheral blood sample) determined as shown in (C) AA and (D) NANA. Horizontal lines show the mean values and each point represents a clone, with the numbers
of clones in each sample stated above the violins. The VH-gene segment usages by clones of different isotypes from all of the bronchial mucosal samples (all 10
biopsies combined) and the peripheral blood were calculated as the percentages of clones assigned to a given VH-gene family within the total number of clones for
each isotype by Alakazam v0.2.5 (13) and plotted for (E) AA and (F) NANA. A dotted line is shown at 5% to highlight the different scaling of the y-axis for VH1-VH4
and VH5-VH7. No sequences using VH7 were found in any of the samples from NANA. The numbers of clones in each category are shown above each bar.
than for clonal overlap (no overlap between AB6 and AB12 to
0.3% (24 of 11153 sequences) between AB3 and AB1), suggesting
that the B cells mature and accumulate SHM and/or undergo
isotype switching during migration between the biopsy sites. This
conclusion was supported by the clonal trees (Figures 5C,D).
One example lineage tree (Figure 5C) spanned five biopsies with
sequences from each biopsy found in separate branches. A second
tree (Figure 5D) displayed a similar pattern of sequences from
two different biopsies in separate branches. This tree furthermore
showed that two different isotypes could be identified in one of
the biopsies, providing an example of an expanded, mutated and
isotype-switched clone.
Despite this high frequency of shared clones within some
regions of the bronchial mucosa, the overlap analysis also
showed that each biopsy harbored a sizeable number of unique
sequences and clones. As multiple biopsies are difficult to
obtain, we asked whether each additional biopsy was providing
additional information through a clonal diversity rarefaction
analysis (Figures 6A,B). This analysis assesses the increase in
coverage achieved with each additional biopsy by randomly
sampling 1-10 biopsies out of a total number of 10. It can be seen
that each additional biopsy contributed more clones to the total
repertoire and that the growth in coverage did not reach a plateau
in either AA or in NANA. In conclusion, we found a high degree
of clonal sharing between biopsies from different parts of the
bronchial mucosa, but we also found that each biopsy contained
a high number (range 10–331) of single biopsy origin clones
corresponding to 38–76% of all the clones within the biopsy (data
not shown).
Higher Connectivity Between Clones From
Biopsies Taken Within Close Proximity
Based on the high frequency of shared B cell clones within
the bronchial mucosa (Figures 5A,B) we wished to investigate
whether or not clonal expansion in the bronchial mucosa is
focused locally. We calculated the clonal relatedness between
all possible sample pairs and used multidimensional scaling to
visualize these distances between samples (see Supplementary
Methods). Visually it appeared that sequences from biopsies
sampled from the same sites in the bronchial tree (Figures 7A,B)
tended to be more closely related than those from biopsies from
more distal sites (Figures 7C,D). However, the clustering of
biopsies into sites was not perfect. Hence we sought to quantify
this trend by calculating the ratio of distances between pairs of
biopsy samples from the same site and pairs of biopsy samples
from different sites. This ratio was lower than expected for each
of the subjects individually (P = 0.06 for AA and P = 0.11 for
NANA, based on 50,000 permutations), and was significantly
lower when considering both subjects together (P = 0.04 by
Fisher’s test). Thus, B cell clones display a tendency to expand
locally within bronchial mucosa.
To further investigate migration within the bronchial mucosa,
we categorized clones into those found in only one biopsy
(single), clones found in at least two biopsies from the same
site in the bronchial mucosa (local) and clones found in at
least two more distal sites (disseminated). Despite the bias
toward local expansion, many clones were found at multiple
sites in the bronchial mucosa (Figure 5) and we found that
20–30% of all clones were disseminated (data not shown).
There was little variation in the degree of dissemination
between the four sites and between the two individuals.
Some clones spanned all possible combinations of sites, with
∼1% of clones disseminated through all sites (Figures 8A,B).
Sequences from the local clones were less mutated and of
smaller clone size compared to sequences from disseminated
clones, although it should be noted that wide ranges of
mutation frequencies and clones were observed in both groups
(Figures 8C,D). Local clones were intermediate in terms of
size and mutation frequency. This was true for both AA
and NANA, and suggests that B cell migration throughout
the bronchial mucosa is associated with clonal expansion and
SHM.
Bidirectional Travel Between the Bronchial
Mucosa And Peripheral Blood
Having determined that many B-cell clones are disseminated
throughout the bronchial mucosa, we next sought to determine
the relationship between the bronchial mucosa and peripheral
blood compartments. All samples showed good sequencing
coverage (Figures S3A,B) and we found that all biopsy samples,
with the single exception of AB12, shared at least one clone
with the peripheral blood (Figures 5A,B). These shared clones
were sometimes found only in one biopsy but more frequently
in multiple sites within the bronchial mucosa (data not shown).
This connectivity between the bronchial mucosa and blood
involved all isotypes (Figures 9A,B, upper left and lower right
quadrants), with the sharing greatest for clones and sequences
of the same isotype. This was particularly apparent in NANA,
with same-isotype overlaps ranging from 4.1% (24 of 579 clones)
of PB (peripheral blood)-IgG related to L (bronchial mucosa)-
IgG to 14.3% (4 of 28 clones) of L-IgD related to PB-IgD.
In AA the highest degree of clonal overlap between peripheral
blood and bronchial mucosa also involved the same isotype in
both compartments, i.e., 3.3% (17 of 509) of PB-IgA clones
related to L-IgA. Cross-compartmental overlap between different
isotypes was lower in both individuals, ranging from 0.4% (5
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FIGURE 2 | Samples from the asthmatic subject AA show less diversity than those from the healthy individual NANA. Clonal diversity analysis was performed by
Alakazam v0.2.5 (6, 13) using the generalized diversity index proposed by Hill (16) with uniform resampling to correct for sequencing depth. The diversity index (qD)
was calculated over a range of diversity orders (q) and plotted as a smooth curve for (A) all sequences sampled from AA or NANA, (B) all biopsy samples combined
(AB and NB) with peripheral blood as a separate entity (APB and NPB) from AA (prefix; A) and NANA (prefix; N), respectively, (C) all individual samples from AA and
(D) all individual samples from NANA. The Shannon diversity index (E), which equates to q = 1, and the Simpson diversity index (F), q = 2, were plotted for all
individual biopsies from AA and NANA. Horizontal lines indicate the median and the box the 25–75th percentiles.
of 1402 L-IgA clones related to PB-IgD) to 3.8% (22 of 579
PB-IgG clones related to L-IgA) in NANA and 0.5% (2 of 400
PB-IgG clones related to L-IgD) to 2.0% (10 PB-IgA clones
related to L-IgG) in AA. Considering the entire repertoire, the
fraction of clones shared was much higher between individual
biopsy samples than between peripheral blood and biopsies
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FIGURE 3 | The human bronchial mucosa repertoire is diversified by SHM and connected to the peripheral blood compartment. The clones were grouped by isotype
and the mutation frequency for each clone determined separately in the bronchial mucosa (10 biopsies combined, gray violins) and peripheral blood (white violins) of
(A) the asthmatic patient AA and (B) the healthy subject NANA (see Supplementary Methods). No IgE sequences were found in the bronchial mucosa samples. The
lines indicate the median mutation frequencies, while the numbers above the violins indicate the numbers of clones analyzed. *P < 0.05 and ***P < 0.001 indicate that
the median mutation frequencies in the bronchial mucosa and peripheral blood samples were statistically significantly different for all comparisons in both individuals.
(C) For each clone (circle) from AA that contained sequences from both bronchial mucosa and peripheral blood, the median mutation frequencies were calculated
separately for sequences from the bronchial mucosa and the peripheral blood and compared, the dashed line showing equivalence. The histogram above the plot
shows the mutation frequency distribution for all unique sequences from the bronchial mucosa and the histogram on the right the distribution for all unique sequences
from the peripheral blood.
(Figures 5A,B, 9A,B). In AA the highest degree of overlap was
observed between IgM and IgD from the bronchial mucosa
(60.1%: 270 of 449 of L-IgD related to L-IgM) and in NANA
almost half of the bronchial mucosal IgG clones overlapped with
IgA (49.1%: 458 of 933 L-IgG related to L-IgA). In general,
there was a high degree of overlap between all isotypes within
the bronchial mucosa (28-60% at the clonal level and 2.4–
21% at the sequence level requiring total sequence homology)
(Figures 9A,B, lower left quadrants). Overall, this analysis clearly
demonstrated that B cells of all isotypes can travel between the
bronchial mucosa and the peripheral blood in both asthmatics
and healthy individuals.
To investigate the directionality of migration, we analyzed
lineage trees for the 34 clones from AA and 55 from NANA
with sequences in both the bronchial mucosa and the peripheral
blood. We reasoned that if B cell migration between the
two compartments is unidirectional, then the sequences from
either the bronchial mucosa or the peripheral blood would
fall consistently closer to the top node of the tree (i.e.,
would have undergone less mutation). Manual inspection of
the lineage trees showed that in some clonal trees the least
mutated sequence was from the peripheral blood and in
others from the bronchial mucosa. Indeed, in some cases
the least mutated node contained a sequence found in both
peripheral blood and the mucosa (example in Figure 9C).
This was true for both AA and NANA. We also established
that mucosal and blood members in each of these shared
clones had similar mean mutation frequencies (Figure 3C).
Taken together these data suggest that B cells migrate between
the bronchial mucosa and peripheral blood in a bidirectional
manner.
IgD-Only B Cells Are Prevalent in the
Asthmatic Bronchial Mucosa
As noted earlier, B cells in bronchial biopsies from AA contained
a high proportion of IgD sequences, whereas IgD was rarely seen
in the mucosa of NANA (Figures 1A,B). Furthermore, some of
these tissue IgD sequences were highly mutated, with a mean
mutation frequency (6.7%) similar to that of IgG (7.1%) and
IgA (6.5%) (Figure 3A). The IgD sequences appeared, however,
to segregate into two groups with low and high mutation
frequencies (Figure 3A). A special subset of IgD-only cells has
been described in the upper respiratory tract (25). These cells
have a high mutation frequency (26, 27), and have lost the ability
to co-express IgM and IgD through deletion of the IgM region
in a class switch recombination event utilizing a cryptic switch
region upstream of the IgD constant region (28). To investigate
the possibility that some of the IgD sequences found in the
bronchial mucosa of AA might originate from such IgD-only
cells, we divided the IgD sequences into two groups—sequences
from clones that contained both IgD and IgM sequences (IgD/M)
and sequences from clones that contained IgD but no observed
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FIGURE 4 | Negative selection in framework regions and neutral to positive selection in complementarity determining regions suggest antigen-driven selection in all
cell subsets. BASELINe (24) was used to calculate the posterior distribution of selection strengths (
∑
) for complementarity determining regions (CDR) and framework
regions (FWR) for each isotype in each sample; (A) AA bronchial mucosa (AA lung), (B) AA peripheral blood, (C) NANA bronchial mucosa (NANA lung), and (D) NANA
peripheral blood were calculated and plotted as smooth curves. IgD and IgD/M for NANA bronchial mucosa were excluded because an insufficient number of
sequences was available for analysis. Curves for the FWRs are shown in the lower half and curves for the CDRs are shown in the upper half of each panel. The white
areas indicate positive selection and the gray areas indicate negative selection. Whereas the selection strength on the FWR is negative in all samples, it is slightly
positive on the CDR in AA bronchial mucosa, AA peripheral blood and NANA peripheral blood, but neutral in NANA bronchial mucosa. All calculations were done
using the “calcBaseline” and “groupBaseline” functions from SHazaM (13) (v0.1.4).
IgM sequences (IgD). In IgD/M clones, we found that the
mutation frequency of IgD and IgM sequences from the same
clone was highly correlated (Figure 10A), suggesting that these
clones represent cells expressing both IgD and IgM, even though
we did not observe both isotypes for every single sequence,
presumably as a result of incomplete sampling and sequencing
depth. The clones spanned a range of mutation frequencies but
only a few fell in the highly mutated range that was prevalent for
the IgD sequences (Figure 10A—histogram on the right).
With few exceptions, the mutation frequencies of the IgD-
only bronchial mucosal clones were significantly higher than
those of the IgD/M clones (P < 0.05) (Figure 11). Analysis
of the mutation patterns in these sequences revealed that they
corresponded to hot- and cold-spot preferences typical of SHM
(Figure S2B) suggesting that the high mutation load had been
generated by normal SHM. The selection strength also appeared
to be similar in the two cell subsets (Figure 4A). Figures 10B,C
show the clonal trees from two IgD/M clones, both found in one
biopsy only (AB11 and AB9, respectively) and both containing
three major types of nodes: (1) IgD only, (2) IgM only and
(3) both IgD and IgM. In both trees, the least mutated node
contained a germline sequence found as both IgM and IgD. All
sequences within the trees had very few mutations. In contrast,
the tree in Figure 10D is from an IgD-only clone. This clone
contained heavily mutated sequences found in four different
biopsies (AB1, AB3, AB13, and AB15). These analyses further
strengthen the conclusion that the bronchial mucosa from the
asthmatic subject contains highly mutated, IgD-only clones.
Certain IgD-only cells have been reported to be auto-reactive
(29), to have specificity against respiratory pathogens (30) or
Frontiers in Immunology | www.frontiersin.org 9 September 2018 | Volume 9 | Article 1976
Ohm-Laursen et al. Diversification and Dissemination of Human Bronchial B Cells
FIGURE 5 | B cells migrate throughout the bronchial mucosa. The numbers of shared clones (top triangle) and sequences (bottom triangle) between all pairs of
samples were calculated for (A) the asthmatic patient AA and (B) the healthy subject NANA. Numbers on the diagonal indicate the total numbers of clones (top) or
unique sequences (bottom) per sample, with the off-diagonal numbers indicating the numbers of shared clones or sequences respectively. Percentages were
calculated by dividing by the number of clones or unique sequences in the smaller of the two samples, and darker colors indicate higher overlap. Sequence overlap
required nucleotide equivalence across the entire VDJ region, but not the constant region. (C) A lineage tree for a heavily expanded IgM clone from AA with members
distributed across multiple mucosal biopsies. The biopsy sample is indicated by the number within each node, and the number on each line denotes the number of
SHM. (D) A lineage tree of a dual isotype, expanded clone from AA with members from biopsy 1 (IgG and IgA) and biopsies 13 and 15 (IgG only). Square nodes with
an “I” label indicate inferred sequences.
to be driven by superantigen (31). In view of this, to further
characterize the sequences from the IgD-only clones, we analyzed
their VH gene usage as described in Figure 1 (Figure 12A). In
peripheral blood we observed no significant difference between
the IgD-only and IgD/M groups, but in bronchial mucosa VH1
was statistically significantly under-represented in the IgD-only
clones compared with the IgD/M clones (P = 2.2e−16 by Fisher’s
test), whereas VH2 was over-expressed (P = 2.2e−16 by Fisher’s
test). VH3 and VH4 were the most frequently used VH genes
as seen for the other immunoglobulin isotypes (Figure 1E) and
with these gene families we observed no significant disparity
of expression in the IgD/M and the IgD-only clones. However,
when we restricted the analysis to the VH3-30 gene, which
has previously been reported to be over-expressed by IgD-only
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FIGURE 6 | Every biopsy contributes new information about the bronchial mucosal repertoire. The total numbers of clones were determined for all permutations of
sampling 1 to 10 biopsies out of a total number of 10 from (A) the asthmatic patient AA and (B) the healthy subject NANA. At each subsampling depth of n biopsies,
there are 10!/[n!(10-n)!] ways to choose from a total of 10 biopsies. For each of these samplings of n biopsies, the percentages of unique clones were calculated
relative to the total number of clones when considering all 10 biopsies. The diamond-shaped black dots indicate the median percentages and the gray bars the
25−75th quartiles. The numbers at the top indicate the median numbers of unique clones across the permutations.
cells (31), we observed that VH3-30 was indeed significantly
over-expressed in the bronchial mucosal IgD-only B cell clones
compared with both the mucosal IgD/M clones (P < 0.001 by
Fisher’s test) and the peripheral blood IgD-only clones (P < 0.001
by Fisher’s test) (data not shown). Genes from the VH5, VH6, and
VH7 families were expressed in only a tinyminority of the clones,
with VH5 detected only in clones from the bronchial mucosa in
agreement with our finding of elevated VH5 usage in the mucosa
compared with the peripheral blood. Thus, IgD-only cells in the
bronchial mucosa showed a distinct pattern of VH gene usage.
Sequences from IgD-only cells have also been reported
to have longer CDR3 regions with more arginine compared
to other isotypes as well as to over-express JH6 (29). We
did not find a higher percentage of arginine in the CDR3
region of the IgD-only clones compared to IgD/M clones (P
= 0.21). We did however find that the IgD-only clones had
statistically significantly longer CDR3 regions (P = 0.01) and
statistically significant over-expression of JH6 (P = 2.5 x 10−4)
(Figures 12B–D, respectively). As JH6 is the longest of the JH
gene segments, we were interested to see whether these long
CDR3 regions reflected the over-usage of JH6. This was not
the case, since we found that for clones using JH1-5, IgD-only
cells also had significantly longer CDR3 regions than IgD/M
clones (P = 0.001) (data not shown). Interestingly, IgD-only
clones using JH6 did not have significantly longer CDR3 regions
compared to IgD/M clones (data not shown), suggesting that
IgD-only clones are selected for long CDR3s per se. Thus, the
IgD-only clones identified in our dataset appeared to be from
a special subset of B cells displaying a high degree of SHM,
long CDR3 regions and increased usage of JH6 and the VH3-30
gene, in line with previous reports on IgD-only cells. In terms of
dissemination, the IgD clones conformed with the patterns seen
with the other isotypes in that most clones were found in one
biopsy only (76%), a few were found to be locally expanded (2%)
and somewere disseminated between distant sites (22%). None of
the IgD-only clones had clonal members found in the peripheral
blood.
DISCUSSION
B cells and the antibodies they produce constitute a significant
plank of the mucosal host defense barrier against the panoply
of environmental assaults to which they are exposed. Study of
the construction of this barrier is a considerable challenge: our
knowledge of the extent and genesis of the airways mucosal B-
cell antibody repertoire is almost non-existent. This is partly
because the total surface area of the mucosa is very large, while
ethical and practical constraints dictate that only small areas
can be sampled at any one time. The new and rapidly evolving
technique of Adaptive Immune Receptor Repertoire Sequencing
(AIRR-Seq) affords new opportunities to characterize the extent
and evolution of the local immunoglobulin repertoire from small
samples, and this study represents the first application of AIRR-
Seq to study B cells in relatively small individual biopsies from
the human bronchial mucosa.
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FIGURE 7 | B cells tend to expand locally within the bronchial mucosa. Two or three bronchial biopsies were sampled from each of four distinct sites within the
bronchial tree of (A) an asthmatic patient AA and (B) a healthy subject NANA. Multidimensional scaling was used to visualize the relatedness of individual samples
from (C) AA and (D) NANA. Relatedness was defined by the Manhattan distances of normalized clone counts as detailed in Supplementary Methods: “Connectivity
analysis.” Label colors correspond to the four distinct sites within the lung in (A) AA and (B) NANA.
We have here characterized the immunoglobulin repertoire in
B cells from contemporaneous samples of the bronchial mucosa
and the peripheral circulation in two subjects, one asthmatic,AA,
as a prototypical airways mucosal inflammatory disease, and one
healthy subject, NANA. Previous studies pointed to geographical
variability within the bronchial mucosa in the numbers of B
cells and antibody specificities (32) and appearance of B cell
clusters in some of the biopsies (33). We therefore decided to
examine multiple regions of the mucosa between the carina and
the 4th generation bronchi of the lower lobe of the right lung
(Figure 7), with several samples from each of those sites. In
total we analyzed 10 biopsies from four distinct sites from each
individual. For all biopsy samples the sequence coverage was very
high (Figure S3) suggesting that we could identify the antibody
sequences from most of the B cells from each biopsy. AIRR-
Seq showed that the biopsies contained between 50 and 500 B
cell clones (Figure 1), in line with the B cell numbers estimated
in our immunohistochemical and flow cytometric analyses of
dissociated bronchial biopsies [(33) and unpublished results].
The repertoires from both the bronchial biopsies and the
peripheral blood exhibited diversity in the expression of different
isotypes, VH gene usage and SHM (Figure 1).While the VH gene
usage was broadly similar in the bronchial mucosa and peripheral
blood of both subjects, resembling that previously reported from
blood in the normal population (18), we did observe over-
expression of the VH5 family genes in the mucosa compared to
peripheral blood in both subjects, confirming previous reports in
asthma (17, 34) and in other atopic diseases: rhinitis (5, 35) and
atopic dermatitis (36).
It has been suggested that the over-expression of VH5 by the
B cells of the bronchial mucosa could reflect the activity of a
local B cell superantigen, possibly a common virus or commensal
bacterium (17). There is some precedent for this hypothesis
as Domiati-Saad et al. have shown that Staphylococcus aureus
enterotoxin D (SED) and SEA can act as B cell superantigens by
rescuing B cells utilizing VH4 and VH3 genes, respectively, from
apoptosis in vitro (37, 38). We have also previously identified
one such superantigen, SEE, in nasal polyps from patients
with chronic rhinosinusitis (39). The blood IgE compartment
in atopic asthmatic children has previously been found to
exhibit a classical, antigen-driven response inconsistent with a
superantigen driven response (40), whereas the IgE compartment
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FIGURE 8 | Some expanded clones have clonal members found in four sites within the bronchial mucosa. The numbers of clones overlapping between any
combination of the four different bronchial mucosal sites sampled (carina and 1st to 3rd or carina and 1st, 3rd, and 4th generation lower lobe, respectively) were
determined along with the number of clones contained in a single site for (A) the asthmatic subject AA and (B) the healthy subject NANA. The percentages refer to the
percentages of the total repertoire from the bronchial mucosa of each individual. 0.7% (AA) and 1% (NANA) of all clones were found in all four sites, but the majority of
the clones were found in only one site. Clones were divided into three groups (i) clones found in one biopsy only (single, blue dots), (ii) clones found in two to three
biopsies from the same site (local, green dots) and (iii) clones found in at least two biopsies from at least two different sites (disseminated, red dots). For each of these
categories and each of the four isotypes, the average clone mutation frequency was plotted against the log of the clone size for (C) the asthmatic subject AA and
(D) the healthy subject NANA. In both individuals the disseminated clones appear, on average, to be larger and more mutated than the single clones with the less
frequent local clones falling somewhere in the middle. No differences were found between the four isotypes analyzed.
in blood of young children with atopic dermatitis, does indeed
display skewed VH gene usage and low levels of somatic
hypermutation, which may be interpreted as signs of activation
by a superantigen (41). The superantigen hypothesis has also
been invoked to explain a skewed VH gene usage in IgD-only
cells. Seifert et al. observed that over 30% of peripheral blood
IgD-only cells and 50% of tonsillar IgD-only cells utilized VH3-
30 (31). We also observed a strong bias toward usage of the VH3-
30 gene (46% of bronchial mucosa IgD-only sequences), along
with the statistically significant over-expression of VH2 and
under-expression of VH1 family genes in IgD-only compared to
IgD/M sequences in AA (Figure 12), supporting the hypothesis
that superantigens or antigens expressing a repeating (e.g.
carbohydrate) epitope may be involved in the activation of IgD-
only cells.
After the various quality control steps we could not detect
IgE transcripts in any of the bronchial mucosal samples from
the asthmatic patient AA and only one from the healthy subject
NANA, although they were found in blood. This may reflect
our earlier experience with irreproducibility in analyzing mRNA
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FIGURE 9 | B cells of all isotypes can travel between the bronchial mucosa and peripheral blood. For each of the two subjects (A) the asthmatic patient AA and
(B) the healthy subject NANA, the bronchial mucosal-derived clonal sequences were pooled and split into isotypes. For all pairs of isotype-specific bronchial mucosa
and isotype-specific peripheral blood samples, the numbers and percentages of overlap between clones (top triangle) and unique sequences (bottom triangle) were
computed as in Figure 3. The lower left hand quadrant shows the overlaps between all pairs of isotype-specific bronchial mucosal samples, the upper left hand
quadrant shows the overlaps between all pairs of isotype-specific mucosal and peripheral blood samples at clonal level, the upper right hand quadrant shows the
overlap between all pairs of isotype-specific peripheral blood samples and the lower right hand quadrant shows the overlaps between all pairs of isotype-specific
mucosal and peripheral blood samples at the unique sequence level. (C) A representative clonal lineage tree from AA containing IgM sequences from peripheral blood
(PB, green), biopsy 13 (13, yellow), and both (13/PB, purple). (D) A lineage tree for a heavily mutated IgA clone from AA with sequences from both peripheral blood
(PB, green) and biopsy 1 (1, yellow). Square nodes with an “I” label indicate inferred sequences.
from small bronchial biopsies, which we attributed to the
relatively low copy number of expressed epsilon mRNA in the
biopsies (unpublished results). We found that the IgE primers
used for amplification had very high homology with IgG. This
increases the risk of mispriming and subsequent quality control
failure, especially with low mRNA copy numbers, whereas
amplification of the higher numbers of epsilon transcripts in
the peripheral blood samples would be possible. The number
of detectable IgE sequences and clones in the peripheral blood
was higher in the healthy subject than the asthmatic patient,
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FIGURE 10 | The mutation frequencies of IgD and IgM sequences from the same clone are highly correlated. (A) For each clone containing both IgM and IgD
sequences from the atopic asthmatic AA bronchial biopsies, the median mutation frequency was calculated separately for IgM sequences and IgD sequences. Each
circle represents one clone. The histogram on the right shows the mutation frequency for all IgD sequences from the bronchial biopsies and the histogram on top the
mutation frequency for all IgM sequences for the bronchial biopsies. Lineage trees for two IgD/M clones from AA biopsies 11 (B) and 9 (C) showing dual IgD/M nodes
(blue), along with separate IgD (orange) and IgM (purple) nodes. (D) A heavily mutated and expanded IgD-only clone with members from AA biopsies 1 (light green), 3
(yellow), 13 (red), and 15 (blue). Square nodes with an “I” label indicate inferred sequences.
possibly reflecting the higher total serum IgE concentration in
the former (see Supplementary Materials). In both subjects the
peripheral blood IgE repertoire displayed a broad VH-gene usage
in line with previous reports of IgE repertoires in both atopic and
non-atopic individuals (42–44) and in allergen-specific IgEs (45).
We noted a significantly wider geographical variability of
the total immunoglobulin repertoire in the bronchial mucosa
of the asthmatic patient compared with that of the healthy
subject. This was both in terms of isotype distribution, mean
mutation frequency, and measures of diversity (Shannon and
Simpson indexes) (Figures 1, 2). In contrast, the overall size of
the repertoire was significantly less diverse (Figure 2), which
we interpret as reflecting ongoing B cell clonal amplification
within the inflamed mucosa of the asthmatic patient. This is
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FIGURE 11 | IgD-only clones from the bronchial biopsies are highly mutated. Clones containing IgD sequences from each of the 10 bronchial mucosal biopsies and
peripheral blood from the asthmatic patient AA were divided into two groups according to whether the clone also contained IgM sequences (IgD/M) or not (IgD).
Within each group, the mutation frequency of a clone (points) was summarized as the median mutation frequency of IgD sequences. Horizontal lines indicate the
mean mutation frequencies for the clones in the given sample category. The numbers of clones in each sample are shown above each violin. *P < 0.05, **P < 0.01
and ***P < 0.001 indicate a significant difference between the median mutation frequencies for IgD in IgD/M and IgD in IgD-only clones from the given sample.
supported by our finding of higher numbers of unmutated and
presumably naïve IgM/IgD cells in the mucosa of the asthmatic
compared with the healthy subject (Table 1 and Figure 1A,B),
which also points to a more focused subset of B cells in
the bronchial mucosa of the asthmatic that are continuously
activated, resulting in larger clones and a oligoclonal response.
The drivers for this oligoclonal response remain to be clarified.
Intuitively, a host of environmental factors may influence the
shaping of the immunoglobulin repertoire of B cells at a mucosal
surface exposed to the external environment in ways that are
not yet well defined. In the case of asthma these might include,
amongst others, the effects of topical medications, exposure
to environmental proteins including aeroallergens, intercurrent
respiratory tract infections, severity and longevity of disease and
exposure to environmental pollutants, including cigarette smoke.
Further dissection of the influences of these various factors will
require further studies with carefully chosen patient and control
subject cohorts.
Remarkably, we uncovered clear evidence that B cell clones
from any one site in the bronchial mucosa can be widely
disseminated within the mucosa and further that the more a
given clone has expanded and mutated, the more likely it is
to have migrated to a remote site within the bronchial mucosa
(Figure 8). In both subjects we found that the B cells from
within each of the four distinct sites analyzed tended to have a
higher degree of clonal overlap compared with those in biopsies
from more distal sites (Figure 7). This suggests that there is
local proliferation, SHM and migration of B cells in situ as well
as widespread trafficking of B cells between different sites in
the mucosa, a potentially vital protective defense mechanism
that may have been established in evolution. The potential
significance of this trafficking is that a selected B cell clone
directed against an antigen originating at one site in the bronchial
mucosa may sensitize the entire bronchial mucosa.
We have previously shown that expression of the components
required for B cell SHM and class switch recombination, such
as AID, can be detected in the bronchial mucosa itself (2).
It is also possible that these events might occur, at least
partly, at discrete sites such as inducible bronchial associated
lymphoid tissue, iBALT, identifiable in the bronchial mucosa of
at least some asthmatics, but more difficult to find in healthy
controls (46–48). This may in turn reflect the observation that
the airways of asthmatics are more susceptible to a range
of environmental assaults, most notably bacterial and viral
infections, which may promote the formation of the germinal
center-like structures in iBALT that may persist for months
after the initial assault, causing chronic inflammation (46, 48).
If B cell maturation takes place in iBALT, one can envisage
that the B cells may migrate directly both to local and more
distal sites within the lung through the local blood or lymphatic
networks. Lymphatic vessels are known to surround iBALT,
although their exact function is unknown (48). In future
studies it would be interesting to compare the B cell antibody
repertoire in the bronchial mucosa of both lungs with that of
the peripheral blood, as this would likely throw more light on
the pathways of B cell migration in the bronchial mucosa, and
particularly whether it occurs predominantly locally or via the
lymphatics/systemic circulation. Nevertheless, the data presented
here are similar to those obtained in the gastrointestinal
tract by Holtmeier et al. who observed expanded IgA clones
from multiple and distant sites across the colonic mucosa
in four healthy individuals. As in the present study in the
bronchial mucosa, a minority of these clones was also found in
blood (8).
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FIGURE 12 | The IgD-only repertoire is distinct from the IgD/M repertoire. Clones containing IgD sequences from the asthmatic patient AA were divided into two
groups according to whether the clone also contained IgM sequences (IgD/M) or not (IgD). (A) The VH gene usages for IgD clones from the two groups from the
(Continued)
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FIGURE 12 | bronchial mucosa (L) and peripheral blood (PB) were calculated and plotted as described for Figure 1E with the numbers of clones in each category
shown above each bar. For each of the two groups, the (B) arginine content and (C) length of the CDR3 region, as defined by IMGT, was calculated. Horizontal lines
indicate the median and the box the 25–75th percentiles. (D) The JH gene usage for IgD clones from IgD/M and IgD-only clones was calculated and plotted as
described for Figure 1E.
It has been demonstrated that the B cell repertoires in the gut
and airways mucosa are distinct (9), and that the repertoires from
different sites in each organ appear to show greater overlap than
those between the organs and the peripheral blood. This could
reflect the possibility that local migration of B cells within an
organ or mucosal surface does not involve the peripheral blood.
Alternatively, it may reflect the fact that the blood contains a
mixture of B cell clones activated in various organs and exposed
to a distinct range of environmental assaults, as well as others
that may originate in the germinal centers of systemic lymph
nodes. It would follow that the B cell repertoire in a sample of
peripheral blood is unlikely to represent the total repertoire in
blood, so that even some of the largest clones in the mucosal
surfaces of organs may be too diluted to appear in a small sample
of blood. Keeping these points in mind, our observed degree of
overlap of the B cell clones in different regions of the bronchial
mucosa (Figures 5, 8) may result from the trafficking of clones
through the blood and homing back to various sites in the tissue,
and/or emigration from, then re-entry into the mucosa as they
pass by distal branches of the draining lymphatics before exiting
the lung. The latter scenario would support our finding that
trafficking between the bronchial mucosa and peripheral blood
is bi-directional (Figure 9) and without a clear indication of the
initiation site for B cell expansion and maturation. In contrast
to our findings, a study in multiple sclerosis using AIRR-Seq
on paired tissue samples suggested that the progenitors of the
expanded, antigen-experienced B cell clones sequenced from the
brain originated in the draining cervical lymph nodes. The clones
subsequently migrated to, and potentially further diversified in
more distant regions of the nervous system (6). The mechanism
of B cell dissemination in the bronchial mucosa may differ
from that in the brain given that the B cells are continuously
exposed to environmental or endogenous antigens and that the
mucosa is supplied with a rich network of blood vessels and
populated with its own lymphoid tissue. The Stern study (6)
does, however, demonstrate that B cells traffic between tissue
and periphery, which is in line with the results of the present
study.
The precise role of IgD antibody remains elusive (30). IgD is
expressed both by IgM+IgD+ cells by alternative splicing of the
pre-mRNA and also by isotype switched, IgD+ only cells (26, 30).
The latter are sparse in the circulation and the bone marrow,
but more frequent in germinal centers and the extra-follicular
areas of, for example, the nasal mucosa and tonsils (27, 30). Here
we provide the first concrete evidence for the presence of IgD-
only B cells within the bronchial mucosa. We identified the IgD-
only sequences based on a greater degree of SHM than those
from clonal families that included IgM sequences (Figure 11). A
high propensity for SHM in IgD-only cells has previously been
described as an important feature of this cell subset (26, 27, 31).
We also found that the sequences from IgD-only cells had
significantly longer CDR3 regions and over-expressed VH3-30
and JH6 (Figure 12), in line with previous reports (29, 31).
Long CDR3 regions are often associated with auto-reactivity,
and Koelch et al. found that some IgD-only cells produced
antibodies against nuclear antigens, single- and double-stranded
DNA and/or human epithelial type 2 cells (29). It has also been
shown that some IgDs have specificity for respiratory pathogens
such as Haemophilus influenzae types a and b and Moraxella
catarrhalis (30), and that the serum concentrations of allergen-
specific IgD correlate with those of allergen-specific IgE in atopic
subjects (49). Circulating, secreted IgD can bind to basophils
and mast cells through an uncharacterized receptor, and cross-
linking of this IgD on the basophils results in the release of pro-
inflammatory mediators including TNF-α and IL-1β, and B cell
activating factors including IL-4, IL-3, BAFF, and APRIL (28, 30).
It is reported that IgD-only cells cannot undergo class
switching to downstream isotypes in the immunoglobulin heavy
chain locus (26). This is supported by our data where fewer
than 10% of IgD-only clones contained sequences of the IgA
or IgG isotype, and furthermore analysis of the clonal trees
suggested that class switch to the downstream isotypes might
have occurred before the loss of IgM expression. Nevertheless,
we hypothesize that highly mutated bronchial mucosal IgD
from IgD-only cells may be involved in asthma pathogenesis by
increasing the diversity of the total immunoglobulin repertoire
that, for example, could play a role in augmenting local mucosal
inflammation. This could be through cross-linking of specific IgD
on the surface of mast cells and/or basophils, resulting in the
release of pro-inflammatory mediators as described above. With
this in mind, it is interesting that we found high numbers of
IgD-only B cells only in the bronchial mucosa of the asthmatic
subject. Very few IgD sequences were found in the B cells in
the bronchial mucosal biopsies of the healthy subject, but those
that were found were typically highly mutated and from IgD-
only clones (80% bronchial mucosa IgD), which reveals that
IgD-only B cells can also be found in the non-diseased state.
We suggest that either the numbers may be too small to cause
damage or, in line with the hypothesis from Chen et al. (28, 30),
that their roles may lie more in enhancing mucosal immunity
than in disease pathogenesis. Our results echo a recent study
in which elevated numbers of IgD+ plasmablasts and increased
soluble IgD was found in nasal tissue in patients with chronic
rhinosinusitis compared with controls (50).
In summary, in this manuscript we show that AIRR-Seq
is a powerful tool for analyzing the B cell repertoire from
individual biopsies from multiple sites of the bronchial mucosa.
Conventional methods such as immunohistochemistry can be
used to enumerate the various cell types in the tissue, but only
AIRR-Seq can provide information about clonal relationships,
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SHM and VH gene usage, relevant for understanding the
diversity and focus of the local antibodies. Our analyses have
produced important and novel information concerning a high
degree of connectivity of clonal B cell development in widely
spaced regions of the bronchial mucosa and bi-directional travel
of cells between mucosa and the peripheral blood. Thus we
here provide proof of principle that AIRR-Seq can unlock data
which will enable understanding the initiation and propagation
of antibody responses at environmental interfaces such as the
respiratory mucosa, and an opportunity to investigate variability
in this response which may be linked with phenotypes/genotypes
of disease severity and longevity, modification by therapy and
environmental exposure. Our analyses also reveal that the B
cell repertoire in the bronchial mucosa of the asthma patient is
less diverse and hence more focused, and contains more naïve
cells than that of a healthy subject. To discover whether these
characteristics are truly related to disease status, we are currently
engaged in a study using AIRR-Seq as a highly sensitive method
to characterize the B cell repertoire in mucosal tissue in a larger
group of individuals. Finally, for the first time, we have identified
sequences from IgD-only B cells in the lower respiratory tract
mucosa and shown that AIRR-Seq can be used to characterize
the repertoire properties of these elusive cells, affording new
ways in which to discover the triggers and effector functions of
IgD antibodies in the pathophysiology of asthma and potentially
other airways mucosal diseases.
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